Supplementary Figure 1 from Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study
Authors:
- Melissa AlsinaMAMelissa Alsina
- Nina ShahNSNina Shah
- Sundar JagannathSJSundar Jagannath
- Jonathan L. KaufmanJKJonathan L. Kaufman
- David SiegelDSDavid Siegel
- Nikhil C. MunshiNMNikhil C. Munshi
- Jacalyn RosenblattJRJacalyn Rosenblatt
- Yi LinYLYi Lin
- Andrzej J. JakubowiakAJAndrzej J. Jakubowiak
- Benjamin A. DermanBDBenjamin A. Derman
- Aojun LiALAojun Li
- Pingping MaoPMPingping Mao
Open Access
- 2 April 2026
- other
- Published by American Association for Cancer Research (AACR)